New UK e-learning module on ME for doctors. Try it yourself and send to your doctor.-

[Countrygirl]

https://www.studyprn.com/p/chronic-...5joq3IvzTMQ1lOQ0r5_vyz1oU8hBbezTwSi4is63KGuv4

I belong to a small group of doctors and patients with ME and one of the members, Dr Nina Muirhead BA(oxon) BMBCh(oxon) MRCS DOHNS MEd PGDipDerm has been working on elearning modules on ME for doctors. Once she had prepared a module, she let us loose on it. Now she has completed it and it is available for everyone to try and I think she has done an excellent job. See for yourself.

If you live in the UK, please do send it to your GP. It is CPD registered so the doctor who completes the module gains a point towards their post-graduate education........if they pass, of course.

Doctors are allowed one hour to complete it. It takes patients about twenty minutes and we score much higher results than the doctors, of course.

Do try it by clicking on the link above.

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome CPD

This free resource, composed of 10 clinical cases, will assess your knowledge of ME/CFS. You'll receive 1 hour of CPD on successful completion of the resource.
Access length:

• 12 months

Extend access FREE

Resource Overview
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a common and severe complex multisystem disease with many sufferers waiting years for a diagnosis. The narrative and education to date has neither aligned with the patient experience of this illness, nor communicated the emerging biomedical evidence.
Following the coronavirus pandemic thousands of people will know how severe and debilitating the symptoms of fatigue can be. Millions will understand the experience of being housebound, but for most these experiences will have lasted days, weeks or months.

Imagine feeling viral, exhausted, unwell and in pain, confined to your bed or house, lying in a dark room for years or even decades. The world has been shocked by the damage that viruses can do, and soon we will need to examine the consequences of chronic post-viral illness including ME/CFS.
In writing this module I have started from scratch. I have drawn on the international peer reviewed literature and emerging international ME/CFS educational resources and have been fortunate to receive significant contributions from medical experts, scientists and patients.

I am humbled by the contributions of those who are severely ill and the effort and energy they have devoted to this collaboration. I recommend that you read the four pre-course peer reviewed papers before embarking on the learning module. It would be of great help if you could take a minute to click through the pre-and post-course questionnaire so that more accurate information can be gathered to help develop and update future ME/CFS learning materials.

This module is just the start. There will be some who take time picking through the evidence and I welcome your opinion and future collaboration. For others it may be an extra CPD point. For the patients who are recognised, believed and diagnosed because you have taken the time to do this learning module – it could be life changing.
Author: Dr Nina Muirhead BA(oxon) BMBCh(oxon) MRCS DOHNS MEd PGDipDerm. Dr Muirhead is also also associated with or alumni of: Oxford University, Open University, Cardiff University, Buckinghamshire Healthcare NHS Trust, the Royal College of Surgeons and the Royal College of Physicians.

Aims and Objectives

• To update professionals with the evolving international biomedical narrative on ME/CFS
• To identify post exertional malaise as a principal feature of ME/CFS
• To gain an understanding of the main diagnostic features of ME/CFS
• To identify commonly comorbid conditions related to ME/CFS
• To recognise the importance of early and accurate diagnosis
• To be aware of differential diagnoses that may emerge, both when considering a diagnosis of ME/CFS, and following a diagnosis of ME/CFS
• To consider the common relevant blood tests and investigations for excluding alternative diagnoses and establishing disease features relevant to ME/CFS
• To summarise the dangers of prescribing exercise for ME/CFS
• To evaluate the needs of individuals in formulating treatment plans and propose the need for development of disease-specific pharmacological management
• To judge the impact on quality of life with an emphasis on the importance of listening to, believing and supporting patients, and families, affected by ME/CFS
• To appreciate that ME/CFS affects minority groups
• To establish a cognisance of the heterogeneous nature of the condition, common patterns of onset, the fluctuating levels of ability, variability in presentation, course of illness and outcomes, and range of severity including mild, moderate, severe and very severe
• To appreciate the importance of providing patients with relevant documentation in connection with applications for state benefits and social and community care